Silva, M.d.O.;                     Castro-Amarante, M.F.;                     Venceslau-Carvalho, A.A.;                     Almeida, B.d.S.;                     Daher, I.P.;                     Souza-Silva, G.A.d.;                     Yamamoto, M.M.;                     Koike, G.;                     de Souza, E.E.;                     Wrenger, C.;     
    et al.    Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein. Vaccines 2024, 12, 356.
    https://doi.org/10.3390/vaccines12040356
    AMA Style
    
                                Silva MdO,                                 Castro-Amarante MF,                                 Venceslau-Carvalho AA,                                 Almeida BdS,                                 Daher IP,                                 Souza-Silva GAd,                                 Yamamoto MM,                                 Koike G,                                 de Souza EE,                                 Wrenger C,         
        et al.        Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein. Vaccines. 2024; 12(4):356.
        https://doi.org/10.3390/vaccines12040356
    
    Chicago/Turabian Style
    
                                Silva, Mariângela de Oliveira,                                 Maria Fernanda Castro-Amarante,                                 Alexia Adrianne Venceslau-Carvalho,                                 Bianca da Silva Almeida,                                 Isabela Pazotti Daher,                                 Guilherme Antonio de Souza-Silva,                                 Marcio Massao Yamamoto,                                 Gabriela Koike,                                 Edmarcia Elisa de Souza,                                 Carsten Wrenger,         
         and et al.        2024. "Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein" Vaccines 12, no. 4: 356.
        https://doi.org/10.3390/vaccines12040356
    
    APA Style
    
                                Silva, M. d. O.,                                 Castro-Amarante, M. F.,                                 Venceslau-Carvalho, A. A.,                                 Almeida, B. d. S.,                                 Daher, I. P.,                                 Souza-Silva, G. A. d.,                                 Yamamoto, M. M.,                                 Koike, G.,                                 de Souza, E. E.,                                 Wrenger, C.,                                 Ferreira, L. C. d. S.,                                 & Boscardin, S. B.        
        
        (2024). Enhanced Immunogenicity and Protective Effects against SARS-CoV-2 Following Immunization with a Recombinant RBD-IgG Chimeric Protein. Vaccines, 12(4), 356.
        https://doi.org/10.3390/vaccines12040356